{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:32:40Z","timestamp":1773923560269,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31171427"],"award-info":[{"award-number":["31171427"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["30971651"],"award-info":[{"award-number":["30971651"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["30700974"],"award-info":[{"award-number":["30700974"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.jcyt.2015.02.014","type":"journal-article","created":{"date-parts":[[2015,4,6]],"date-time":"2015-04-06T06:29:23Z","timestamp":1428301763000},"page":"956-968","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Clinical efficacy of autologous stem cell transplantation for the treatment of patients with type 2 diabetes mellitus: a meta-analysis"],"prefix":"10.1016","volume":"17","author":[{"given":"Zheng-Xu","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Xia","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Long","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yishan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bei-Lei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-Bo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2015.02.014_bib1","first-page":"2247","article-title":"A\u00a0clinical trial to maintain glycemic control in youth with type 2 diabetes","volume":"24","author":"Zeitler","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcyt.2015.02.014_bib2","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1056\/NEJMoa0908292","article-title":"China National Diabetes and Metabolic Disorders Study Group. Prevalence of diabetes among men and women in China","volume":"12","author":"Yang","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcyt.2015.02.014_bib3","doi-asserted-by":"crossref","first-page":"269","DOI":"10.5001\/omj.2012.68","article-title":"Type 2 diabetes mellitus: a review of current trends","volume":"4","author":"Olokoba","year":"2012","journal-title":"Oman Med J"},{"key":"10.1016\/j.jcyt.2015.02.014_bib4","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nbt841","article-title":"Bone marrow-derived stem cells initiate pancreatic regeneration","volume":"21","author":"Hess","year":"2003","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jcyt.2015.02.014_bib5","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.scr.2013.02.005","article-title":"Generation of islet-like cells from mouse gall bladder by direct ex\u00a0vivo reprogramming","volume":"1","author":"Hickey","year":"2013","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.jcyt.2015.02.014_bib6","doi-asserted-by":"crossref","first-page":"8948","DOI":"10.1073\/pnas.1220637110","article-title":"Brief demethylation step allows the conversion of adult human skin fibroblasts into insulin-secreting cells","volume":"22","author":"Pennarossa","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcyt.2015.02.014_bib7","doi-asserted-by":"crossref","first-page":"e63491","DOI":"10.1371\/journal.pone.0063491","article-title":"Reversal of hyperglycemia by insulin-secreting rat bone marrow- and blastocyst-derived hypoblast stem cell-like cells","volume":"5","author":"Kumar","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jcyt.2015.02.014_bib8","doi-asserted-by":"crossref","first-page":"249","DOI":"10.4161\/isl.20856","article-title":"Preparation of pancreatic \u03b2-cells from human iPS cells with small molecules","volume":"3","author":"Hosoya","year":"2012","journal-title":"Islets"},{"key":"10.1016\/j.jcyt.2015.02.014_bib9","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1634\/stemcells.2007-0267","article-title":"Mesenchymal stem cells cooperate with bone marrow cells in therapy of diabetes","volume":"1","author":"Urb\u00e1n","year":"2008","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2015.02.014_bib10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.5966\/sctm.2012-0031","article-title":"Impaired therapeutic capacity of autologous stem cells in a model of type 2 diabetes","volume":"2","author":"Shin","year":"2012","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.jcyt.2015.02.014_bib11","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1001\/jama.299.8.925","article-title":"Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases","volume":"8","author":"Burt","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.jcyt.2015.02.014_bib12","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.bbmt.2010.04.014","article-title":"Efficacy and safety of ex\u00a0vivo cultured adult human mesenchymal stem cells (Prochymal) in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study","volume":"4","author":"Prasad","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2015.02.014_bib13","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1001\/jama.2009.470","article-title":"C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus","volume":"15","author":"Couri","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jcyt.2015.02.014_bib14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.autrev.2011.09.003","article-title":"New hope for type 2 diabetics: targeting insulin resistance through the immune modulation of stem cells","volume":"2","author":"Zhao","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jcyt.2015.02.014_bib15","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.3727\/096368908787648119","article-title":"Combined treatment of intrapancreatic autologous bone marrow stem cells and hyperbaric oxygen in type 2 diabetes mellitus","volume":"12","author":"Estrada","year":"2008","journal-title":"Cell Transplant"},{"key":"10.1016\/j.jcyt.2015.02.014_bib16","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jcyt.2013.10.004","article-title":"Autologous bone marrow mononuclear cell infusion and hyperbaric oxygen therapy in type 2 diabetes mellitus: an open-label, randomized controlled clinical trial","volume":"16","author":"Wu","year":"2014","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2015.02.014_bib17","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1089\/scd.2009.0164","article-title":"Efficacy of autologous bone marrow-derived stem cell transplantation in patients with type 2 diabetes mellitus","volume":"10","author":"Bhansali","year":"2009","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.jcyt.2015.02.014_bib18","first-page":"3622","article-title":"Autologous bone marrow stem cell transplantation for the treatment of type 2 diabetes mellitus","volume":"22","author":"Wang","year":"2011","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.jcyt.2015.02.014_bib19","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1507\/endocrj.EJ12-0092","article-title":"Long term effects of the implantation of autologous bone marrow mononuclear cells for type 2 diabetes mellitus","volume":"11","author":"Hu","year":"2012","journal-title":"Endocr J"},{"key":"10.1016\/j.jcyt.2015.02.014_bib20","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.3727\/096368913X665576","article-title":"Efficacy and Safety of Autologous Bone Marrow Derived Stem Cell Transplantation in patients with Type 2 Diabetes mellitus: A randomized placebo-controlled study","volume":"23","author":"Bhansali","year":"2014","journal-title":"Cell Transplant"},{"key":"10.1016\/j.jcyt.2015.02.014_bib21","first-page":"5126","article-title":"Value of targeting intervention technology in autologous peripheral blood stem cells therapy of type 2 diabetes mellitus","volume":"17","author":"Ding","year":"2012","journal-title":"Chin J Clinicians"},{"key":"10.1016\/j.jcyt.2015.02.014_bib22","first-page":"4355","article-title":"Autologous bone marrow cell transplantation via spleen artery in 5 patients with type 2 diabetes Mellitus","volume":"23","author":"Wang","year":"2010","journal-title":"J\u00a0Clinical Rehabilitative Tissue Engineering Research"},{"key":"10.1016\/j.jcyt.2015.02.014_bib23","first-page":"22","article-title":"The clinical observation of umbilical cord blood stem cell transplantation on the treatment of type 2 diabetes","volume":"11","author":"Xu","year":"2011","journal-title":"China Medicine and Pharmacy"},{"key":"10.1016\/j.jcyt.2015.02.014_bib24","first-page":"74","article-title":"Efficacy and safety of autologous bone marrow stem cells transplantation for type 2 diabetes mellitus","volume":"1","author":"Yao","year":"2012","journal-title":"J\u00a0Third Mil Med Univ"},{"issue":"Suppl","key":"10.1016\/j.jcyt.2015.02.014_bib25","first-page":"A544","article-title":"Sustained effect of autologous bone marrow mononuclear cell transplantation in-patients with diabetes: 12 Month follow-up. 67th Annual Meeting of the American-Diabetes-Association. 2008 JUN 06-10 San Francisco","volume":"57","author":"Chen","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.jcyt.2015.02.014_bib26","doi-asserted-by":"crossref","first-page":"E1501","DOI":"10.1210\/jc.2013-1451","article-title":"Improved Insulin Secretion Following Intrapancreatic UCB Transplantation in Patients With T2D","volume":"9","author":"Tong","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jcyt.2015.02.014_bib27","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/scrt446","article-title":"A\u00a0preliminary evaluation of efficacy and safety of Wharton's jelly mesenchymal stem cell transplantation in patients with type 2 diabetes mellitus","volume":"5","author":"Liu","year":"2014","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jcyt.2015.02.014_bib28","first-page":"1452","article-title":"Exploring the clinical efficacy of the umbilical cord blood stem cell transplantation on the treatment of type 2 diabetes","volume":"35","author":"Wang","year":"2014","journal-title":"Journal of Qiqihar University of Medicine"},{"key":"10.1016\/j.jcyt.2015.02.014_bib29","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/1741-7015-11-160","article-title":"Targeting insulin resistance in type 2 diabetes via immune modulation of cord blood-derived multipotent stem cells (CB-SCs) in stem cell educator therapy: phase I\/II clinical trial","volume":"11","author":"Zhao","year":"2013","journal-title":"BMC Med"},{"key":"10.1016\/j.jcyt.2015.02.014_bib30","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.arr.2013.01.001","article-title":"Generating insulin-producing cells for diabetic therapy: existing strategies and new development","volume":"2","author":"Shen","year":"2013","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.jcyt.2015.02.014_bib31","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2217\/rme.09.74","article-title":"Stem cell paracrine actions and tissue regeneration","volume":"1","author":"Baraniak","year":"2010","journal-title":"Regen Med"},{"key":"10.1016\/j.jcyt.2015.02.014_bib32","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.2337\/db10-0542","article-title":"Congenic mesenchymal stem cell therapy reverses hyperglycemia in experimental type 1 diabetes","volume":"59","author":"Jurewicz","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.jcyt.2015.02.014_bib33","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.clim.2010.04.010","article-title":"Immunological and regenerative properties of cord blood stem cells","volume":"136","author":"Francese","year":"2010","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jcyt.2015.02.014_bib34","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jss.2008.03.019","article-title":"Adipose tissue-derived cells improve cardiac function following myocardial infarction","volume":"2","author":"Schenke-Layland","year":"2009","journal-title":"J\u00a0Surg Res"},{"key":"10.1016\/j.jcyt.2015.02.014_bib35","doi-asserted-by":"crossref","unstructured":"Maguire G, Friedman P. The Systems Biology of Stem Cell Released Molecules-Based Therapeutics. 2013; Article ID 784541, 12 pages. http:\/\/dx.doi.org\/10.1155\/2013\/784541.","DOI":"10.1155\/2013\/784541"},{"key":"10.1016\/j.jcyt.2015.02.014_bib36","first-page":"20","article-title":"Autologous bone marrow mesenchymal stem cell transplantation for the treatment of type 2 diabetes","volume":"17","author":"Zhou","year":"2013","journal-title":"Contemporary Medicine"},{"key":"10.1016\/j.jcyt.2015.02.014_bib37","first-page":"7","article-title":"Regulation of blood glucose by administration of allogenic bone marrow derived mesenchymal stem cells into diabetic rats through modulating regeneration of both \u03b1 and \u03b2 islet cells","volume":"2","author":"Meng","year":"2013","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.jcyt.2015.02.014_bib38","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1210\/er.2011-0008","article-title":"Immunological applications of stem cells in type 1 diabetes","volume":"32","author":"Fiorina","year":"2011","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jcyt.2015.02.014_bib39","unstructured":"Osiris Therapeutics provides update on groundbreaking stem cell trial for type 1 diabetes. Osiris Therapeutics, Inc. web site. http:\/\/investor.osiris.com\/releasedetail.cfm?ReleaseID_636520; [accessed 10.10.13]."},{"key":"10.1016\/j.jcyt.2015.02.014_bib40","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.2337\/db14-0295","article-title":"Autologous nonmyeloablative hematopoietic stem cell transplantation in new-onset type 1 diabetes: a multicenter analysis","volume":"63","author":"D'Addio","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.jcyt.2015.02.014_bib41","doi-asserted-by":"crossref","first-page":"993","DOI":"10.4049\/jimmunol.0900803","article-title":"Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes","volume":"183","author":"Fiorina","year":"2009","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jcyt.2015.02.014_bib42","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1634\/stemcells.2005-0403","article-title":"Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation","volume":"24","author":"Miura","year":"2006","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2015.02.014_bib43","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1634\/stemcells.2005-0620","article-title":"Sarcoma derived from cultured mesenchymal stem cells","volume":"25","author":"Tolar","year":"2007","journal-title":"Stem Cells"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S146532491500078X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S146532491500078X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:21:38Z","timestamp":1761430898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S146532491500078X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":43,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S146532491500078X"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2015.02.014","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical efficacy of autologous stem cell transplantation for the treatment of patients with type 2 diabetes mellitus: a meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2015.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}